Alpha Omega Wealth Management’s Novartis NVS Stock Holding History

Alpha Omega Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,013	Closed	-$92K	–	442
2019 Q2	$92K	Sell	1,013 -114	-10%	-$9.65K	0.04%	202
2019 Q1	$97K	Hold	1,127	–	–	0.04%	194
2018 Q4	$87K	Hold	1,127	–	–	0.04%	190
2018 Q3	$87K	Hold	1,127	–	–	0.04%	188
2018 Q2	$76K	Hold	1,127	–	–	0.04%	195
2018 Q1	$82K	Hold	1,127	–	–	0.04%	181
2017 Q4	$85K	Sell	1,127 -38	-3%	-$2.87K	0.04%	185
2017 Q3	$90K	Hold	1,165	–	–	0.04%	181
2017 Q2	$87K	Hold	1,165	–	–	0.04%	182
2017 Q1	$78K	Hold	1,165	–	–	0.04%	191
2016 Q4	$76K	Buy	+1,165	New	+$75.6K	0.04%	203

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Alpha Omega Wealth Management's NVS Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 1,013 shares — an estimated $92K sold.

Alpha Omega Wealth Management first reported a position in NVS in Q4 2016 and held it in 11 quarters. The position peaked at $97K in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 1,013 Novartis shares in Q3 2019, an estimated $92K.
Alpha Omega Wealth Management first reported a position in Novartis in Q4 2016 and held it in 11 quarters.
Alpha Omega Wealth Management's Novartis position peaked at $97K in Q1 2019.
1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.